Appointment New Patient Appointment or 214-645-8300

MedBlog

Ankit Kansagra, M.D.

Cancer; Discovery

Multiple myeloma care: Taking CAR T-cell therapy for rare blood cancer to the next level

As new CAR T-cell therapies are being approved to treat certain cancers, Ankit Kansagra, M.D., explains how the UT Southwestern team is working to further revolutionize treatment for more cancer patients.

Cancer; Heart

AL amyloidosis treatments offer patients hope and potentially a cure

A new, FDA-approved four-drug combo for AL amyloidosis is improving longevity and quality of life dramatically. Ankit Kansagra, M.D., discusses how the medication and a multidisciplinary team of experts can give patients longer, healthier lives.

Heart

New drugs for cardiac amyloidosis provide hope for patients

For decades, there were no FDA-approved treatments for cardiac amyloidosis in the U.S. But in the last two years, two new therapies were approved for cardiac- and nerve-related ATTR. In this week's MedBlog, Justin Grodin, M.D., discusses these therapies and what they mean for North Texas patients.

Cancer

CAR-T therapy: Genetically-engineered cells that fight blood cancer

CAR-T therapy could provide a lifesaving treatment option for blood cancer patients who have undergone multiple rounds of chemotherapy without going into remission. Discover how CAR-T therapy works and who might benefit.